In a statement, Merck said an analysis of real-world data from an Israeli study, known as Clalit, showed that Lagevrio reduced hospitalisations and deaths due to COVID-19 in patients 65 years and ...

Merck has shipped around 6.4 million courses of Lagevrio around the world to date, showing strong demand outside the US, but is expecting sales of the drug going forward to be weaker than expected.

Sales of Merck's Covid antiviral pill, Lagevrio, also fell 40% to $383 million during the quarter. Still, that topped ...

and lower sales of COVID antiviral Lagevrio. Outside of China, Gardasil sales grew by double-digits in almost every major ...

Merck & Co., Inc. operates as a healthcare company ... and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting ...

lower sales of the COVID-19 medication LAGEVRIO, lower sales of GARDASIL/GARDASIL 9 and lower sales of SIMPONI and REMICADE, reflecting the transfer of marketing rights in former Merck territories ...